[1] Guzman MG,Harris E. Dengue[J]. Lancet,2015,385(9966):453-465. DOI:10.1016/S0140-6736(14)60572-9. [2] Arima Y,Chiew M,Matsui T. Epidemiological update on the dengue situation in the Western Pacific Region,2012[J]. Western Pac Surveill Response J,2015,6(2):82-89. DOI:10.5365/WPSAR.2014.5.4.002. [3] Tambo E,Chen JH,Zhou XN,et al. Outwitting dengue threat and epidemics resurgence in Asia-Pacific countries:strengthening integrated dengue surveillance,monitoring and response systems[J]. Infect Dis Poverty,2016,5(1):56. DOI:10.1186/s40249-016-0148-3. [4] Guo CC,Zhou ZX,Wen ZH,et al. Global epidemiology of dengue outbreaks in 1990-2015:A systematic review and meta-analysis[J]. Front Cell Infect Microbiol,2017,7:317. DOI:10.3389/fcimb.2017.00317. [5] 赵峥,李昱,牟笛,等. 2016-2018年中国重点省份境外输入性登革热病例的时空分析[J]. 中华流行病学杂志,2020,41(11):1808-1812. DOI:10.3760/cma.j.cn112338-20191231-00923. Zhao Z,Li Y,Mou D,et al. Spatial-temporal analysis on imported dengue fever in six provinces of China,2016-2018[J]. Chin J Epidemiol,2020,41(11):1808-1812. DOI:10.3760/cma.j.cn112338-20191231-00923.(in Chinese) [6] 岳玉娟,吴海霞,李贵昌,等. 2005-2013年中国大陆登革热病例空间分析[J]. 现代预防医学,2016,43(8):1345-1348,1354. Yue YJ,Wu HX,Li GC,et al. Spatial analysis of dengue fever in mainland China between 2005 and 2013[J]. Mod Prev Med,2016,43(8):1345-1348,1354. (in Chinese) [7] 周克梅,杨明东,兰学梅,等. 云南省129个县(市、区)主城区登革热媒介伊蚊分布调查[J]. 中国媒介生物学及控制杂志,2021,32(2):150-157. DOI:10.11853/j.issn.1003.8280.2021. 02.006. Zhou KM,Yang MD,Lan XM,et al. An investigation of the distribution of dengue vector Aedes in the main urban areas of 129 counties (cities,districts) of Yunnan province,China[J]. Chin J Vector Biol Control,2021,32(2):150-157. DOI:10. 11853/j.issn.1003.8280.2021.02.006.(in Chinese) [8] 刘起勇. 我国登革热流行新趋势、防控挑战及策略分析[J]. 中国媒介生物学及控制杂志,2020,31(1):1-6. DOI:10.11853/j.issn.1003.8280.2020.01.001. Liu QY. Dengue fever in China:new epidemical trend,challenges and strategies for prevention and control[J]. Chin J Vector Biol Control,2020,31(1):1-6. DOI:10.11853/j.issn.1003.8280. 2020.01.001.(in Chinese) [9] Cao JQ,Deng H,Ye L,et al. Epidemiological and clinical characteristics of dengue virus outbreaks in two regions of China,2014-2015[J]. PLoS One,2019,14(3):e0213353. DOI:10. 1371/journal.pone.0213353. [10] Gubler DJ. Dengue and dengue hemorrhagic fever[J]. Clin Microbiol Rev,1998,11(3):480-496. DOI:10.1128/CMR.11. 3.480. [11] Zhong DL,Luo SX,Zheng LL,et al. Epilepsy occurrence and circadian rhythm:A bibliometrics study and visualization analysis via CiteSpace[J]. Front Neurol,2020,11:984. DOI:10.3389/fneur.2020.00984. [12] Sun YY,Zhang NS,Zhou J,et al. Distribution,contents,and types of mycosporine-like amino acids (MAAs) in marine macroalgae and a database for MAAs based on these characteristics[J]. Mar Drugs,2020,18(1):43. DOI:10.3390/md18010043. [13] 陈悦,陈超美,刘则渊,等. CiteSpace知识图谱的方法论功能[J]. 科学学研究,2015,33(2):242-253. DOI:10.3969/j.issn. 1003-2053.2015.02.009. Chen Y,Chen CM,Liu ZY,et al. The methodology function of CiteSpace mapping knowledge domains[J]. Stud Sci Sci,2015,33(2):242-253. DOI:10.3969/j.issn.1003-2053.2015.02.009.(in Chinese) [14] Sirisena PDNN,Noordeen F. Evolution of dengue in Sri Lanka-changes in the virus,vector,and climate[J]. Int J Infect Dis,2014,19:6-12. DOI:10.1016/j.ijid.2013.10.012. [15] Khetarpal N,Khanna I. Dengue fever:causes,complications,and vaccine strategies[J]. J Immunol Res,2016,2016:6803098. DOI:10.1155/2016/6803098. [16] Li CL,Lu YM,Liu JN,et al. Climate change and dengue fever transmission in China:Evidences and challenges[J]. Sci Total Environ,2018,622-623:493-501. DOI:10.1016/j.scitotenv. 2017.11.326. [17] Luo L,Jiang LY,Xiao XC,et al. The dengue preface to endemic in mainland China:the historical largest outbreak by Aedes albopictus in Guangzhou,2014[J]. Infect Dis Poverty,2017,6(1):148. DOI:10.1186/s40249-017-0352-9. [18] 习佳成,程晓敏,胡欢,等. 1990-2018年广东省登革热流行的时间动态规律[J]. 热带医学杂志,2020,20(4):460-464. DOI:10.3969/j.issn.1672-3619.2020.04.009. Xi JC,Cheng XM,Hu H,et al. Temporal dynamic of dengue fever in Guangdong province from 1990 to 2018[J]. J Trop Med,2020,20(4):460-464. DOI:10.3969/j.issn.1672-3619.2020.04.009.(in Chinese) [19] 赵建国,贾巧娟,王丽莹,等. 气象因素对登革热传播影响的研究进展[J]. 现代预防医学,2020,47(22):4185-4189. Zhao JG,Jia QJ,Wang LY,et al. Research advances in the impacts of meteorological factors on dengue transmission[J]. Mod Prev Med,2020,47(22):4185-4189. (in Chinese) [20] Uno N,Ross TM. Dengue virus and the host innate immune response[J]. Emerg Microbes Infect,2018,7(1):167. DOI:10.1038/s41426-018-0168-0. [21] Green AM,Beatty PR,Hadjilaou A,et al. Innate immunity to dengue virus infection and subversion of antiviral responses[J]. J Mol Biol,2014,426(6):1148-1160. DOI:10.1016/j.jmb.2013. 11.023. [22] Deval H,Behera SP,Agrawal A,et al. Genetic characterization of dengue virus serotype 2 isolated from dengue fever outbreaks in eastern Uttar Pradesh and western Bihar,India[J]. J Med Virol,2021,93(6):3322-3329. DOI:10.1002/jmv.26239. [23] Tripathi NK,Shrivastava A. Recent developments in recombinant protein-based dengue vaccines[J]. Front Immunol,2018,9:1919. DOI:10.3389/fimmu.2018.01919. [24] Kliks SC,Nisalak A,Brandt WE,et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever[J]. Am J Trop Med Hyg,1989,40(4):444-451. DOI:10.4269/ajtmh.1989.40.444. [25] Acosta EG,Bartenschlager R. Paradoxical role of antibodies in dengue virus infections:considerations for prophylactic vaccine development[J]. Expert Rev Vaccines,2016,15(4):467-482. DOI:10.1586/14760584.2016.1121814. [26] Shukla R,Ramasamy V,Shanmugam RK,et al. Antibody-dependent enhancement:a challenge for developing a safe dengue vaccine[J]. Front Cell Infect Microbiol,2020,10:572681. DOI:10.3389/fcimb.2020.572681. [27] Rodriguez-Roche R,Blanc H,Bordería AV,et al. Increasing clinical severity during a dengue virus type 3 Cuban epidemic:deep sequencing of evolving viral populations[J]. J Virol,2016,90(9):4320-4333. DOI:10.1128/JVI.02647-15. [28] Manakkadan A,Joseph I,Prasanna RR,et al. Lineage shift in Indian strains of dengue virus serotype-3(Genotype III),evidenced by detection of lineage IV strains in clinical cases from Kerala[J]. Virol J,2013,10:37. DOI:10.1186/1743-422X-10-37. [29] Mo L,Shi JD,Guo XF,et al. Molecular characterization of an imported dengue virus serotype 4 isolate from Thailand[J]. Arch Virol,2018,163(10):2903-2906. DOI:10.1007/s00705-018-3906-7. [30] Ko HY,Salem GM,Chang GJJ,et al. Application of next-generation sequencing to reveal how evolutionary dynamics of viral population shape dengue epidemiology[J]. Front Microbiol,2020,11:1371. DOI:10.3389/fmicb.2020.01371. [31] Chen HR,Lai YC,Yeh TM. Dengue virus non-structural protein 1:a pathogenic factor,therapeutic target,and vaccine candidate[J]. J Biomed Sci,2018,25(1):58. DOI:10.1186/s12929-018-0462-0. [32] Biering SB,Akey DL,Wong MP,et al. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction[J]. Science,2021,371(6525):194-200. DOI:10.1126/science.abc0476. [33] Beatty PR,Puerta-Guardo H,Killingbeck SS,et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination[J]. Sci Transl Med,2015,7(304):304ra141. DOI:10.1126/scitranslmed.aaa3787. |